awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33509626-A00C47C2-7318-4865-AC68-83108B36FCC5
Q33509626-A00C47C2-7318-4865-AC68-83108B36FCC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33509626-A00C47C2-7318-4865-AC68-83108B36FCC5
Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology.
P2860
Q33509626-A00C47C2-7318-4865-AC68-83108B36FCC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33509626-A00C47C2-7318-4865-AC68-83108B36FCC5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5279b07394bd552c7e53a86d19594631394de371
P2860
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.